|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 5/0783 | (2010.01) |
| C07D 401/14 | (2013.01) | ||
| C12N 15/113 | (2010.01) | ||
| C07D 207/34 | (2013.01) | ||
| C07D 295/00 | (2006.01) | ||
| C12N 15/1137 | (2013.01) | ||
| C07D 401/14 | (2006.01) | ||
| C12N2310/14 | (2013.01) | ||
| A61K 35/17 | (2015.01) | ||
| C12N2310/531 | (2013.01) | ||
| C07D 207/34 | (2006.01) | ||
| C12N 5/0636 | (2013.01) | ||
| C07K 16/24 | (2006.01) | ||
| C12N2510/00 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 16/30 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 3397756 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16881286.5 |
| Europos patento paraiškos padavimo data | 2016-12-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-11-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-03-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2016/113612 |
| Data | 2016-12-30 |
| (87) | Numeris | WO 2017/114497 |
| Data | 2017-07-06 |
| (30) | Numeris | Data | Šalis |
| PCT/CN2015/099882 | 2015-12-30 | WO |
| (72) |
MOTZ, Gregory , US
MAVRAKIAS, Konstantinos John , US
LIU, Jinbiao , CN
LIU, Lei , CN
ZHENG, Qiangang , CN
XUN, Guoliang , CN
XIAO, Qitao , CN
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
The Trustees of The University of Pennsylvania , 3600 Civic Center Boulevard, 9th Floor, Philadelphia, PA 19104, US |
| (54) | IMMUNE EFFECTOR CELL THERAPIES WITH ENHANCED EFFICACY |
| IMMUNE EFFECTOR CELL THERAPIES WITH ENHANCED EFFICACY |